NYC Mesothelioma Attorney Calls on New Yorkers to Support the Cause of Cancer Research
New York, NY, May 26, 2012 — New York mesothelioma attorney Joseph W. Belluck today called on every able New Yorker to join the fight against cancer as part of May’s National Cancer Research Month and throughout the year.
“Despite many advances that have been made in the battle against mesothelioma and other cancers, more work needs to be done,” said Belluck, a founding partner of Belluck & Fox, LLP, a New York personal injury firm that provides legal representation to victims of mesothelioma and other asbestos-related diseases.
“Cancer touches everyone and nearly everyone can respond in a manner that helps the cause of cancer research and the eventual elimination of cancer as a threat,” Belluck said.
The U.S. Congress declared May to be National Cancer Research Month in recognition of high quality, innovative cancer research.
“Cancer research is the way forward,” said Judy Garber, M.D., past president of the American Association for Cancer Research (AACR) “It’s the way to make things better.”
But there are many kinds of cancer that require different medical approaches, often varying from patient to patient, Garber said. This makes cancer research a wide ranging and expensive enterprise.
Garber said there are multiple ways individuals can help the cause of cancer research:
- Calling on Congress to make funding the National Cancer Institute and the National Institutes of Health a top priority in the the fiscal year 2013 federal budget.
- Making a donation to the AACR Foundation for the Prevention and Cure of Cancer in honor of a cancer patient or survivor.
- Participating in a clinical trial as a cancer patient or as a healthy participant to help researchers obtain data.
- Learning and being informed about the causes of preventable cancer to help decrease the number of cancer diagnoses in the country.
Pleural mesothelioma is a cancer of the tissue surrounding the lungs that manifests many years after inhaling asbestos fibers, usually from industrial products and machinery at the victim’s workplace. There is no known cure for mesothelioma.
Because mesothelioma is rarer than other cancers, there is typically less money devoted specifically to mesothelioma research, prevention and treatment.
“We’ve worked with many mesothelioma victims and others harmed by asbestos exposure, and we’ve seen the devastation suffered by cancer patients and their families,” Belluck said.
“Recent breakthroughs in mesothelioma research pertaining to treatment are significant advances that provide hope for patients,” he continued. “They also inspire our continued support and admiration for those who are working to solve the mesothelioma puzzle.”
About Belluck & Fox, LLP
Belluck & Fox, LLP, is a nationally recognized law firm that represents individuals with asbestos and mesothelioma claims, as well as victims of crime, motorcycle crashes, lead paint and other serious injuries. The firm provides personalized and professional representation and has won over $400 million in compensation for clients and their families.
Partner Joseph W. Belluck is AV-rated by Martindale-Hubbell and is listed in Best Lawyers in America, New York Magazine’s “Best Lawyers in the New York Area” and in Super Lawyers. Mr. Belluck has won numerous cases involving injuries from asbestos, defective medical products, tobacco and lead paint.
Partner Jordan Fox is a well-known asbestos and mesothelioma attorney who has been named to the Best Lawyers in America, New York Magazine’s “Best Lawyers in the New York Area” and to Super Lawyers. On two separate occasions his verdicts were featured as the National Law Journal’s Largest Verdict of the Year.
Belluck & Fox, LLP, won a coveted spot on a list of America’s best law firms, which was published jointly by U.S. News & World Report and Best Lawyers magazine. The listing showcased 8,782 different law firms ranked in one or more of 81 major practice areas.
For more information, contact the firm at 855-205-2015 or through the online contact form.
Label: Research News